Cognition Therapeutics, Inc. (CGTX) Tops Q2 EPS by 2c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• H.C. Wainwright Reiterates Buy Rating on Cognition Therapeutics (CGTX)
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c